1. Home
  2. JAGX vs BDRX Comparison

JAGX vs BDRX Comparison

Compare JAGX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • BDRX
  • Stock Information
  • Founded
  • JAGX 2013
  • BDRX 2000
  • Country
  • JAGX United States
  • BDRX United Kingdom
  • Employees
  • JAGX N/A
  • BDRX N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JAGX Health Care
  • BDRX Health Care
  • Exchange
  • JAGX Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • JAGX 3.8M
  • BDRX 3.7M
  • IPO Year
  • JAGX N/A
  • BDRX N/A
  • Fundamental
  • Price
  • JAGX $8.06
  • BDRX $1.56
  • Analyst Decision
  • JAGX
  • BDRX
  • Analyst Count
  • JAGX 0
  • BDRX 0
  • Target Price
  • JAGX N/A
  • BDRX N/A
  • AVG Volume (30 Days)
  • JAGX 66.3K
  • BDRX 1.2M
  • Earning Date
  • JAGX 05-13-2025
  • BDRX 05-02-2025
  • Dividend Yield
  • JAGX N/A
  • BDRX N/A
  • EPS Growth
  • JAGX N/A
  • BDRX N/A
  • EPS
  • JAGX N/A
  • BDRX N/A
  • Revenue
  • JAGX $11,689,000.00
  • BDRX N/A
  • Revenue This Year
  • JAGX $38.22
  • BDRX N/A
  • Revenue Next Year
  • JAGX $39.96
  • BDRX N/A
  • P/E Ratio
  • JAGX N/A
  • BDRX N/A
  • Revenue Growth
  • JAGX 19.75
  • BDRX N/A
  • 52 Week Low
  • JAGX $4.02
  • BDRX $1.14
  • 52 Week High
  • JAGX $540.00
  • BDRX $74.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 57.58
  • BDRX 44.22
  • Support Level
  • JAGX $5.00
  • BDRX $1.24
  • Resistance Level
  • JAGX $6.13
  • BDRX $1.52
  • Average True Range (ATR)
  • JAGX 0.87
  • BDRX 0.22
  • MACD
  • JAGX 0.72
  • BDRX 0.06
  • Stochastic Oscillator
  • JAGX 88.07
  • BDRX 47.76

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: